TRIAC disrupts cerebral thyroid hormone action via negative feedback and heterogenous distribution among organs-Reference-Cited by-同舟云学术

TRIAC disrupts cerebral thyroid hormone action via negative feedback and heterogenous distribution among organs

Published:2023-07 Issue:7 Volume:26 Page:107135
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Yamauchi Ichiro^ORCID,Hakata Takuro,Ueda Yohei^ORCID,Sugawa Taku,Omagari Ryo^ORCID,Teramoto Yasuo,Nakayama Shoji F.^ORCID,Nakajima Daisuke^ORCID,Kubo Takuya^ORCID,Inagaki Nobuya^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference45 articles.

1. EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals;Gore;Endocr. Rev.,2015

2. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans;Maia;J. Clin. Invest.,2005

3. Binding characteristics of thyroid hormone distributor proteins to thyroid hormone metabolites;Jongejan;Thyroid,2022

4. Binding of 3,5,3′-Triiodothyronine (T3) and its Analogs to thein VitroTranslational Products of c-erbA Protooncogenes: Differences in the Affinity of the α- and β-Forms for the Acetic Acid Analog and Failure of the Human Testis and Kidney α-2 Products to Bind T3

5. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone;Takeda;J. Clin. Endocrinol. Metab.,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estratificación del riesgo cardiovascular y síndrome metabólico en una cohorte suramericana de pacientes con hipotiroidismo;Revista Salud y Desarrollo;2024-07-08

2. Enhanced molecular recognition with longer chain crosslinkers in molecularly imprinted polymers for an efficient separation of TR active substances;RSC Advances;2024

3. Transcriptomic Landscape of Hyperthyroidism in Mice Overexpressing Thyroid Stimulating Hormone;2023-10-27

4. DESCRIPTION OF THE METABOLIC SYNDROME AND ITS INDIVIDUALIZED RISK IN A LATIN AMERICAN COHORT OF GERIATRIC PATIENTS WITH HYPOTHYROIDISM;2023-09-01